Skip to main content

Table 1 Participant demographics

From: Cognitive enhancing supplements and medications in United States Resident Physicians

Variable

Β 

Sample N (%) (Total = 296)

Gender

Female

144 (48.6%)

Male

120 (40.5%)

Unknown

32 (10.8%)

Married

Yes

136 (45.9%)

No

129 (43.6%)

Prefer not to answer

1 (0.3%)

Children

Yes

54 (18.2%)

No

210 (70.9%)

Prefer not to answer

2 (0.7%)

Primary Specialty

Anatomic Pathology and Clinical Pathology

14 (4.7%)

Anesthesiology

20 (6.8%)

Dermatology

2 (0.7%)

Diagnostic Radiology

8 (2.7%)

Emergency Medicine

9 (3.0%)

Family Medicine

8 (2.7%)

General Surgery

13 (4.4%)

Internal Medicine

49 (16.6%)

Internal Medicine-Pediatrics

4 (1.4%)

Internal Medicine

1 (0.3%)

Neurological Surgery

5 (1.7%)

Neurology

7 (2.4%)

Obstetrics and Gynecology

11 (3.7%)

Ophthalmology

12 (4.1%)

Orthopedic Surgery

11 (3.7%)

Otolaryngology

4 (1.4%)

Pediatrics

34 (11.5%)

Physical Medicine and Rehabilitation

7 (2.4%)

Plastic Surgery

7 (2.4%)

Prefer not to answer

14 (4.7%)

Psychiatry

17 (5.7%)

Radiation Oncology

1 (0.3%)

Triple Board (Pediatrics, Psychiatry, Child and Adolescent Psychiatry)

4 (1.4%)

Urology

4 (1.4%)

Specialty

Surgical

67 (22.6%)

Non-surgical

199 (67.2%)

Learning disorder or disability

No

265 (89.5%)

/

31 (10.5%)

Attention deficit hyperactivity disorder (ADHD)

Yes

21 (7.1%)

No

245 (82.8%)

/

30 (10.1%)

Shift work sleep disorder

Yes

23 (7.8%)

No

242 (81.8%)

/

31 (10.5%)

Narcolepsy

Yes

2 (0.7%)

No

263 (88.9%)

/

31 (10.5%)

Sleep apnea with excessive daytime sleepiness

Yes

4 (1.4%)

No

261 (88.2%)

/

31 (10.5%)

Neurodegenerative disease

No

265 (89.5%)

/

31 (10.5%)

  1. Note: β€˜/’ is missing value. Data represent unweighted percentages